Proteasomal Indoleamine 2,3-Dioxygenase Degradation Reduces the Immunosuppressive Potential of Clinical Grade-Mesenchymal Stromal Cells Undergoing Replicative Senescence - Archive ouverte HAL Access content directly
Journal Articles Stem Cells / Stem Cells (Miamisburg) Year : 2017

Proteasomal Indoleamine 2,3-Dioxygenase Degradation Reduces the Immunosuppressive Potential of Clinical Grade-Mesenchymal Stromal Cells Undergoing Replicative Senescence

Abstract

Owing to their immunosuppressive properties, mesenchymal stromal cells (MSCs) obtained from bone marrow (BM-MSCs) or adipose tissue (ASCs) are considered a promising tool for cell therapy. However, important issues should be considered to ensure the reproducible production of efficient and safe clinical-grade MSCs. In particular, high expansion rate, associated with progressive senescence, was recently proposed as one of the parameters that could alter MSC functionality. In this study, we directly address the consequences of replicative senescence on BM-MSC and ASC immunomodulatory properties. We demonstrate that MSCs produced according to GMP procedures inhibit less efficiently T-cell, but not Natural Killer (NK)- and B-cell, proliferation after reaching senescence. Senescence-related loss-of-function is associated with a decreased indoleamine 2,3-dioxygenase (IDO) activity in response to inflammatory stimuli. In particular, although STAT-1-dependent IDO expression is transcriptionally induced at a similar level in senescent and nonsenescent MSCs, IDO protein is specifically degraded by the proteasome in senescent ASCs and BM-MSCs, a process that could be reversed by the MG132 proteasome inhibitor. These data encourage the use of appropriate quality controls focusing on immunosuppressive mechanisms before translating clinical-grade MSCs in the clinic.
Fichier principal
Vignette du fichier
Proteasomal IDO degradation reduces_accepted.pdf (1.59 Mo) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-01516052 , version 1 (10-07-2017)

Licence

Attribution - ShareAlike - CC BY 4.0

Identifiers

Cite

Séverine Loisel, Joelle Dulong, Cédric Menard, Marie-Laure Renoud, Nadine Meziere, et al.. Proteasomal Indoleamine 2,3-Dioxygenase Degradation Reduces the Immunosuppressive Potential of Clinical Grade-Mesenchymal Stromal Cells Undergoing Replicative Senescence. Stem Cells / Stem Cells (Miamisburg), 2017, 35 (5), pp.1431-1436. ⟨10.1002/stem.2580⟩. ⟨hal-01516052⟩
372 View
171 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More